AAPL343.93+4.43 (+1.30%) ▲|ABBV284.67-4.41 (-1.53%) ▼|ABT100.56-1.89 (-1.84%) ▼|ACN240.28+1.16 (+0.49%) ▲|ADBE255.06-1.67 (-0.65%) ▼|AMAT408.94+3.96 (+0.98%) ▲|AMD552.72+17.98 (+3.36%) ▲|AMGN438.34-0.60 (-0.14%) ▼|AMT177.63-5.93 (-3.23%) ▼|AMZN262.37-0.26 (-0.10%) ▼|AVGO337.80+3.43 (+1.03%) ▲|AXP323.64+5.30 (+1.66%) ▲|BA192.31+1.84 (+0.97%) ▲|BAC50.80+0.16 (+0.32%) ▲|BKNG158.38-5.54 (-3.38%) ▼|BLK1,149.10+20.42 (+1.81%) ▲|BMY61.16-0.53 (-0.85%) ▼|BNY145.85+1.60 (+1.11%) ▲|BRK-B541.16+1.34 (+0.25%) ▲|C123.84+1.33 (+1.08%) ▲|CAT740.16+14.92 (+2.06%) ▲|CL93.42-1.13 (-1.19%) ▼|CMCSA22.08-0.28 (-1.25%) ▼|COF206.49+4.93 (+2.44%) ▲|COP145.70-0.25 (-0.17%) ▼|COST998.31+3.70 (+0.37%) ▲|CRM241.72-0.71 (-0.29%) ▼|CSCO107.26+0.55 (+0.52%) ▲|CVS93.45-1.30 (-1.37%) ▼|CVX226.76+1.05 (+0.46%) ▲|DE636.56+4.36 (+0.69%) ▲|DHR234.02+9.78 (+4.36%) ▲|DIS111.82+0.15 (+0.13%) ▲|DUK120.69-0.64 (-0.53%) ▼|EMR163.13+2.67 (+1.66%) ▲|FDX298.18-0.58 (-0.19%) ▼|GD344.91+0.47 (+0.14%) ▲|GE295.84-4.04 (-1.35%) ▼|GEV926.39+36.06 (+4.05%) ▲|GILD153.57-2.94 (-1.88%) ▼|GM76.10-0.99 (-1.28%) ▼|GOOG330.95-5.45 (-1.62%) ▼|GOOGL334.76-5.52 (-1.62%) ▼|GS904.50+19.69 (+2.23%) ▲|HD314.08-1.03 (-0.33%) ▼|HON214.73+1.41 (+0.66%) ▲|IBM251.06+9.14 (+3.78%) ▲|INTC92.96+1.27 (+1.39%) ▲|INTU335.61+0.32 (+0.10%) ▲|ISRG428.12-9.88 (-2.26%) ▼|JNJ257.65-1.71 (-0.66%) ▼|JPM335.13-0.13 (-0.04%) ▼|KO92.68-0.82 (-0.87%) ▼|LIN500.57-1.32 (-0.26%) ▼|LLY1,272.20-11.46 (-0.89%) ▼|LMT551.97+3.26 (+0.59%) ▲|LOW196.55-0.73 (-0.37%) ▼|LRCX260.81-2.64 (-1.00%) ▼|MA622.50+2.08 (+0.33%) ▲|MCD246.22-0.30 (-0.12%) ▼|MDLZ62.74-1.25 (-1.95%) ▼|MDT93.03-1.60 (-1.69%) ▼|META697.52+3.27 (+0.47%) ▲|MMM174.69+3.32 (+1.94%) ▲|MO73.83-0.81 (-1.09%) ▼|MRK149.89+1.59 (+1.07%) ▲|MS187.11+6.71 (+3.72%) ▲|MSFT532.95+1.08 (+0.20%) ▲|MU913.67+17.60 (+1.96%) ▲|NEE78.25-0.61 (-0.77%) ▼|NFLX65.04-3.65 (-5.31%) ▼|NKE37.53-0.35 (-0.92%) ▼|NOW153.14+3.60 (+2.41%) ▲|NVDA221.97+5.50 (+2.54%) ▲|ORCL129.10-2.04 (-1.56%) ▼|PEP134.70+0.68 (+0.51%) ▲|PFE29.86-0.25 (-0.83%) ▼|PG156.89-2.43 (-1.53%) ▼|PLTR201.72+9.12 (+4.74%) ▲|PM197.47-2.43 (-1.22%) ▼|QCOM177.96+2.25 (+1.28%) ▲|RTX191.60-1.74 (-0.90%) ▼|SBUX99.08-0.29 (-0.29%) ▼|SCHW91.64+0.75 (+0.83%) ▲|SO90.39-0.32 (-0.35%) ▼|SPG205.55-1.44 (-0.70%) ▼|T21.91-1.51 (-6.45%) ▼|TMO694.29+6.92 (+1.01%) ▲|TMUS153.75-4.00 (-2.54%) ▼|TSLA386.47+12.76 (+3.41%) ▲|TXN284.65+6.87 (+2.47%) ▲|UBER67.62-1.32 (-1.91%) ▼|UNH417.00-2.26 (-0.54%) ▼|UNP287.87+0.26 (+0.09%) ▲|UPS99.57+1.05 (+1.07%) ▲|USB59.05-0.04 (-0.07%) ▼|V407.85+1.28 (+0.31%) ▲|VZ43.56-0.98 (-2.20%) ▼|WFC82.42+0.22 (+0.27%) ▲|WMT117.80-0.05 (-0.04%) ▼|XOM178.09+0.23 (+0.13%) ▲|AAPL343.93+4.43 (+1.30%) ▲|ABBV284.67-4.41 (-1.53%) ▼|ABT100.56-1.89 (-1.84%) ▼|ACN240.28+1.16 (+0.49%) ▲|ADBE255.06-1.67 (-0.65%) ▼|AMAT408.94+3.96 (+0.98%) ▲|AMD552.72+17.98 (+3.36%) ▲|AMGN438.34-0.60 (-0.14%) ▼|AMT177.63-5.93 (-3.23%) ▼|AMZN262.37-0.26 (-0.10%) ▼|AVGO337.80+3.43 (+1.03%) ▲|AXP323.64+5.30 (+1.66%) ▲|BA192.31+1.84 (+0.97%) ▲|BAC50.80+0.16 (+0.32%) ▲|BKNG158.38-5.54 (-3.38%) ▼|BLK1,149.10+20.42 (+1.81%) ▲|BMY61.16-0.53 (-0.85%) ▼|BNY145.85+1.60 (+1.11%) ▲|BRK-B541.16+1.34 (+0.25%) ▲|C123.84+1.33 (+1.08%) ▲|CAT740.16+14.92 (+2.06%) ▲|CL93.42-1.13 (-1.19%) ▼|CMCSA22.08-0.28 (-1.25%) ▼|COF206.49+4.93 (+2.44%) ▲|COP145.70-0.25 (-0.17%) ▼|COST998.31+3.70 (+0.37%) ▲|CRM241.72-0.71 (-0.29%) ▼|CSCO107.26+0.55 (+0.52%) ▲|CVS93.45-1.30 (-1.37%) ▼|CVX226.76+1.05 (+0.46%) ▲|DE636.56+4.36 (+0.69%) ▲|DHR234.02+9.78 (+4.36%) ▲|DIS111.82+0.15 (+0.13%) ▲|DUK120.69-0.64 (-0.53%) ▼|EMR163.13+2.67 (+1.66%) ▲|FDX298.18-0.58 (-0.19%) ▼|GD344.91+0.47 (+0.14%) ▲|GE295.84-4.04 (-1.35%) ▼|GEV926.39+36.06 (+4.05%) ▲|GILD153.57-2.94 (-1.88%) ▼|GM76.10-0.99 (-1.28%) ▼|GOOG330.95-5.45 (-1.62%) ▼|GOOGL334.76-5.52 (-1.62%) ▼|GS904.50+19.69 (+2.23%) ▲|HD314.08-1.03 (-0.33%) ▼|HON214.73+1.41 (+0.66%) ▲|IBM251.06+9.14 (+3.78%) ▲|INTC92.96+1.27 (+1.39%) ▲|INTU335.61+0.32 (+0.10%) ▲|ISRG428.12-9.88 (-2.26%) ▼|JNJ257.65-1.71 (-0.66%) ▼|JPM335.13-0.13 (-0.04%) ▼|KO92.68-0.82 (-0.87%) ▼|LIN500.57-1.32 (-0.26%) ▼|LLY1,272.20-11.46 (-0.89%) ▼|LMT551.97+3.26 (+0.59%) ▲|LOW196.55-0.73 (-0.37%) ▼|LRCX260.81-2.64 (-1.00%) ▼|MA622.50+2.08 (+0.33%) ▲|MCD246.22-0.30 (-0.12%) ▼|MDLZ62.74-1.25 (-1.95%) ▼|MDT93.03-1.60 (-1.69%) ▼|META697.52+3.27 (+0.47%) ▲|MMM174.69+3.32 (+1.94%) ▲|MO73.83-0.81 (-1.09%) ▼|MRK149.89+1.59 (+1.07%) ▲|MS187.11+6.71 (+3.72%) ▲|MSFT532.95+1.08 (+0.20%) ▲|MU913.67+17.60 (+1.96%) ▲|NEE78.25-0.61 (-0.77%) ▼|NFLX65.04-3.65 (-5.31%) ▼|NKE37.53-0.35 (-0.92%) ▼|NOW153.14+3.60 (+2.41%) ▲|NVDA221.97+5.50 (+2.54%) ▲|ORCL129.10-2.04 (-1.56%) ▼|PEP134.70+0.68 (+0.51%) ▲|PFE29.86-0.25 (-0.83%) ▼|PG156.89-2.43 (-1.53%) ▼|PLTR201.72+9.12 (+4.74%) ▲|PM197.47-2.43 (-1.22%) ▼|QCOM177.96+2.25 (+1.28%) ▲|RTX191.60-1.74 (-0.90%) ▼|SBUX99.08-0.29 (-0.29%) ▼|SCHW91.64+0.75 (+0.83%) ▲|SO90.39-0.32 (-0.35%) ▼|SPG205.55-1.44 (-0.70%) ▼|T21.91-1.51 (-6.45%) ▼|TMO694.29+6.92 (+1.01%) ▲|TMUS153.75-4.00 (-2.54%) ▼|TSLA386.47+12.76 (+3.41%) ▲|TXN284.65+6.87 (+2.47%) ▲|UBER67.62-1.32 (-1.91%) ▼|UNH417.00-2.26 (-0.54%) ▼|UNP287.87+0.26 (+0.09%) ▲|UPS99.57+1.05 (+1.07%) ▲|USB59.05-0.04 (-0.07%) ▼|V407.85+1.28 (+0.31%) ▲|VZ43.56-0.98 (-2.20%) ▼|WFC82.42+0.22 (+0.27%) ▲|WMT117.80-0.05 (-0.04%) ▼|XOM178.09+0.23 (+0.13%) ▲|
16.8 C
New York
Wednesday, October 21, 2026

Tag: MISSION

newsFORsourcecompanycontentinformation1releasesmarket

The Association of Former Students announces new corporate partnership with Verizon

COLLEGE STATION, Texas, July 23, 2025 (GLOBE NEWSWIRE) -- The Association of Former Students, the official alumni association of Texas A&M University serving approximately 600,000 members of the Aggie Network, is proud to announce a new corporate partnership with Verizon, one of the world’s leading providers of technology and communications services that power and empower how people live, play and work. This partnership will support The Association’s mission to engage, connect and serve the worldwide Aggie Network.

Global X Launches PureCap[SM] Product Suite to Provide Uncapped Sector ETF Exposure

The new suite of ETFs seeks to deliver true market capitalization exposure across five key sectors, addressing rising market concentration trends NEW YORK, July 23, 2025...

BTQ Technologies Unveils Léonne: Quantum-Secure Consensus Framework for Scalable and Decentralized Blockchain Networks

Léonne is the first framework to unify trust modeling, network analysis, and quantum-resistant cryptography into a single, modular, and production-ready system.Léonne facilitates the scalability, security,...

BTQ Technologies Unveils Léonne: Quantum-Secure Consensus Framework for Scalable and Decentralized Blockchain Networks

Léonne is the first framework to unify trust modeling, network analysis, and quantum-resistant cryptography into a single, modular, and production-ready system.Léonne facilitates the scalability, security,...

U.S. Department of Justice to Sponsor Cellebrite for FedRAMP ATO

TYSONS CORNER, Va., July 23, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the U.S. Department of Justice (DOJ) will serve as the official sponsoring agency for the platform's pursuit of a FedRAMP High authorization.

Aidoc Secures $150M for CARE, its Healthcare Foundation Model, to Transform Clinical Decision-Making for 100 Million Patients

The Era of Clinical AI Has Arrived: Trusted by Leading Health Systems, Aidoc's Platform Brings AI to the Heart of Patient Care NEW YORK, July 23,...

October Three Expands Operations with New Office in Indianapolis

October Three announced its expansion with a new office in Indianapolis which will service public plans, as well as non-public plans.

AnyCreek Acquires Origin to Continue Building the Outdoor Industry’s Leading AI-Powered Vertical Software Platform

The combined platform now operates in all 50 states, supports thousands of outfitters and guides, and has powered over 1 million hours of guided...

Learn Capital Releases 2025 Outcomes Report on AI and the Future of Learning

Learn Capital's new outcomes-driven framework highlights how responsible AI investment is transforming human potential through education. IRVINE, Calif., July 23, 2025 /PRNewswire/ -- Learn Capital,...

Relativity Networks Secures $6M Seed Funding to Power the Next-Generation Fiber-Optic Cable for Data Centers, Raising Total to $10.6M

Investors' backing bolsters Relativity Networks' ability to meet the insatiable demand for a data transmission technology that hyperscalers require for the AI-powered economy. ORLANDO, Fla.,...

Sky Quarry’s Nevada-Based Refinery Launches Crowdfunding Campaign

Exploring Digital Asset Strategies to Inform Future Capital Innovation 
Exploring Digital Asset Strategies to Inform Future Capital Innovation

4TEEN4 Doses First Patient in Phase 1b/2a Trial of Procizumab, a Monoclonal Antibody Targeting the Biological Driver of Shock

Hennigsdorf/ Berlin, July 23, 2025 – 4TEEN4 Pharmaceuticals GmbH today announced that the first patient has been dosed in a Phase 1b/2a PROCARD1 clinical trial evaluating its monoclonal antibody, procizumab, in patients with shock caused primarily by cardiogenic events. Shock is a life-threatening condition characterized by a sudden breakdown in circulatory function due to end-stage disease or acute events, which often leads to organ failure. With only symptomatic treatment options available, shock is associated with a high mortality rate of over 50%. The Phase 1b/2a trial is designed to identify a target dose for procizumab in preparation for further clinical development. In addition, the trial will provide signals of efficacy. In a Phase 1 study in healthy volunteers, procizumab was well tolerated.

Guidehouse Research Explores Evolving Electric Vertical Takeoff and Landing Technology Market

eVTOLs are on the verge of full commercial manufacturing and approval BOULDER, Colo., July 23, 2025 /PRNewswire/ -- A new report from Guidehouse Research explores electric vertical takeoff...

Cytovation to Advance Development of CY-101 for Cancers Driven by Dysfunction of Wnt/β-catenin Signalling Under International Nonproprietary Name of Getacatetide

Bergen, Norway, July 23, 2025 – Cytovation ASA, a clinical stage oncology company focused on the development of its first-in-class bifunctional peptide CY-101, announces that the International Nonproprietary Names (INN) Expert Committee of the World Health Organization (WHO-INN) has approved "getacatetide" as the International Nonproprietary Name (INN) of CY-101.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMISSION

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers